These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 2484784)
41. [Removal of low density lipoproteins on dextrans sulfate in 2 patients with familial monogenic hypercholesterolemia]. Aubert I; Bombail D; Erlich D; Goy-Loeper J; Chanu B; Bussel A; Rouffy J Ann Med Interne (Paris); 1988; 139 Suppl 1():72-6. PubMed ID: 2470281 [TBL] [Abstract][Full Text] [Related]
42. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia. Thiery J; Seidel D Transfus Sci; 1993 Jul; 14(3):249-59. PubMed ID: 10146336 [TBL] [Abstract][Full Text] [Related]
43. Lipidfiltration--safe and effective methodology to perform lipid-apheresis. Klingel R; Mausfeld P; Fassbender C; Goehlen B Transfus Apher Sci; 2004 Jun; 30(3):245-54. PubMed ID: 15172630 [TBL] [Abstract][Full Text] [Related]
44. Effects on coronary atherosclerosis of long-term treatment of familial hypercholesterolemia by LDL-apheresis. Mabuchi H; Koizumi J; Michishita I; Takeda M; Kajinami K; Fujita H; Inazu A; Uno Y; Shimizu M; Takeda R Beitr Infusionsther; 1988; 23():87-96. PubMed ID: 2484787 [No Abstract] [Full Text] [Related]
45. Double-filtration plasmapheresis in heterozygous familial hypercholesterolemia: our experience over 25 treatments. Candrina R; Spandrio S; Di Stefano O; Scalvini T; Cotelli M; Tosoni M; Giustina G Beitr Infusionsther; 1988; 23():189-90. PubMed ID: 2484776 [No Abstract] [Full Text] [Related]
46. LDL-apheresis affects markers of endothelial function in patients with homozygous familial hypercholesterolemia. Nenseter MS; Bogsrud MP; Græsdal A; Narverud I; Halvorsen B; Ose L; Aukrust P; Holven KB Thromb Res; 2012 Nov; 130(5):823-5. PubMed ID: 22728023 [No Abstract] [Full Text] [Related]
47. [Double membrane filtration in LDL-apheresis]. Yamamoto A; Kojima S Nihon Rinsho; 1992 Jan; 50 Suppl():374-81. PubMed ID: 1578710 [No Abstract] [Full Text] [Related]
48. [LDL-apheresis in the treatment familial hypercholesterolemia]. Bláha V; Bláha M; Lánská M; Havel E; Vyroubal P; Zadák Z; Žák P; Sobotka L Vnitr Lek; 2014 Nov; 60(11):970-6. PubMed ID: 25600044 [TBL] [Abstract][Full Text] [Related]
49. Plasma exchange and low density lipoprotein apheresis in Watanabe heritable hyperlipidemic rabbits. Kano M; Koizumi J; Jadhav A; Thompson GR Arteriosclerosis; 1987; 7(3):256-61. PubMed ID: 3593072 [TBL] [Abstract][Full Text] [Related]
50. LDL apheresis by dextran sulfate cellulose (DSC) column in two patients with monogenic familial hypercholesterolemia (FH). Aubert I; Bombail D; Erlich D; Goussault Y; Rouffy J; Bussel A Prog Clin Biol Res; 1990; 337():205-7. PubMed ID: 1693782 [No Abstract] [Full Text] [Related]
51. Efficacy of plasmapheresis, cascade-filtration and dextran-sulfate adsorption apheresis with calculation of the recovery rate of lipids and lipoproteins. Schwartzkopff W; Nold A; Gräfenhahn H; von Baeyer H; Schwerdtfeger R Beitr Infusionsther; 1988; 23():103-11. PubMed ID: 2484763 [No Abstract] [Full Text] [Related]
52. Cerebral blood flow velocity and systemic vascular resistance after acute reduction of low-density lipoprotein in familial hypercholesterolemia. Rubba P; Faccenda F; Di Somma S; Gnasso A; Scarpato N; Iannuzzi A; Nappi G; Postiglione A; De Divitiis O; Mancini M Stroke; 1993 Aug; 24(8):1154-61. PubMed ID: 8342189 [TBL] [Abstract][Full Text] [Related]
53. Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis. Homma Y; Mikami Y; Tamachi H; Nakaya N; Nakamura H; Araki G; Goto Y Atherosclerosis; 1986 Apr; 60(1):23-7. PubMed ID: 2423096 [TBL] [Abstract][Full Text] [Related]
54. Hemodynamic changes in the peripheral circulation after repeat low density lipoprotein apheresis in familial hypercholesterolemia. Rubba P; Iannuzzi A; Postiglione A; Scarpato N; Montefusco S; Gnasso A; Nappi G; Cortese C; Mancini M Circulation; 1990 Feb; 81(2):610-6. PubMed ID: 2297866 [TBL] [Abstract][Full Text] [Related]
55. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Yokoyama S; Hayashi R; Satani M; Yamamoto A Arteriosclerosis; 1985; 5(6):613-22. PubMed ID: 3865648 [TBL] [Abstract][Full Text] [Related]
56. Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis, and changes of subfractionated plasma lipoproteins after plasmapheresis in heterozygous familial hypercholesterolemia. Homma Y; Mikami Y; Tamachi H; Nakaya N; Nakamura H; Goto Y Metabolism; 1987 May; 36(5):419-25. PubMed ID: 3574132 [TBL] [Abstract][Full Text] [Related]
57. Some aspects of the use of dextran sulfate-cellulose columns for the treatment of familial hypercholesterolemia. Erlich D; Aubert I; Neel D; Scrobohaci ML; Loreau J; Bussel A; Rouffy J; Dreux C; Goussault Y; Weintraub H Clin Chim Acta; 1991 Sep; 201(3):169-74. PubMed ID: 1756589 [No Abstract] [Full Text] [Related]
58. Selective and semiselective low-density lipoprotein apheresis in familial hypercholesterolemia. Busnach G; Cappelleri A; Vaccarino V; Franceschini G; Dal Col A; Perrino ML; Brando B; Sirtori C; Minetti L Blood Purif; 1988; 6(3):156-61. PubMed ID: 3395475 [TBL] [Abstract][Full Text] [Related]